• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

merger

  1. INFINITY & MEI PHARMA MERGER

    was wondering if anyone works for either company or have any details on this merger that was announced ?? what can I expect market wise?

  2. Pipeline saved with cheap buyout

    seems the executive teams for Biogen and Zosano have been meeting a lot as of late.. backfilling that empty pipeline. apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal. Being scooped up...
    • anonymous
    • Thread
    • buyout merger migraine
    • Replies: 5
    • Forum: Biogen

  3. Bristol-Myers Squibb swallows Celgene for $74 billion

    Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.
    • anonymous
    • Thread
    • acquisition biopharma bristol-myers squibb buyout celgene merger oncology pharmaceuticals specialty takeover
    • Replies: 3
    • Forum: Celgene

  4. Rite Aid narrows earnings outlooks

    Shares of the drug retailer Rite Aid Corp (RAD) tanked on Monday after the company narrowed its fiscal 2019 earnings outlook.

  5. Carl Icahn opposes planned merger of Cigna and Express Scripts

    Billionaire activist investor Carl Icahn has taken a sizable stake in health insurer Cigna (CI) and plans to vote against the proposed merger of Cigna with Express Scripts (ESRX), thereby threatening to scupper the entire deal...

  6. FTC clears Takeda’s acquisition of Shire

    The US Federal Trade Commission (FTC) has given its nod for the proposed $62 billion acquisition of Shire (SHPG) by Japanese firm Takeda Pharmaceuticals. The merger, the largest ever by a Japanese company, was cleared sans any conditions. Takeda plans to close the acquisition during the first...

  7. Stryker says it will not acquire Boston Scientific

    On Monday, WSJ reported that Stryker is in talks with Boston Scientific for a potential acquisition. But today, Stryker confirmed that it didn't have any discussion with Boston Scientific. https://news.alphastreet.com/stryker-confirms-that-it-didnt-bid-for-boston-scientific/
    • anonymous
    • Thread
    • acquisition boston scientific bostonscientific deal healthcare medical device medical equipment merger rumor stryker
    • Replies: 5
    • Forum: Boston Scientific

  8. Is the rumor really true? Are we being acquired?

    I keep hearing little things about us possibly being acquired. Has anyone else heard this? This is coming from reliable sources. I heard it is still very early in the process, but there are talks.
    • anonymous
    • Thread
    • being acquired merger sold
    • Replies: 17
    • Forum: Sunovion

  9. Things happened in healthcare in 2017

    If you ask Sansa Stark from HBO’s Game of Thrones, she’ll tell you the best way to go is to team up with someone strong or risk getting killed. And that’s what happens to most acquisitions in the market nowadays. Over the past three years or so, we have seen a plethora of deal announcements...

  10. Amedica and Zimmer soon to be one

    Told you all this was going to happen. Amedicas 10k out today. Check my blog for updates as today is the start of it all! Find constant updates here and here. https://stocktwits.com/symbol/AMDA https://investorshub.advfn.com/Amedica-Corp-AMDA-27931/
    • Boston745
    • Thread
    • amedica buyout merger zimmer
    • Replies: 323
    • Forum: Zimmer

  11. Immune Pharma merging??? IMNP

    Word on the street is that immune pharma (IMNP) is im talks to merge with a big pharma, maybe allergan. They canceled their lease and paid a significant six figure penalty to get out of it. It doesn't appear they have much of a company left, just an interim CEO to handle the transition...
Top Bottom
Back